T-wave morphology abnormalities in the STREAM stage 1 trial

CONCLUSIONS: T-wave abnormalities may help identify patients at risk of QT prolongation on DR-TB treatment.TRIAL REGISTRATION: The trial is registered at ClinicalTrials.gov (CT.gov identifier: NCT02409290). Current Controlled Trial number, ISRCTN78372190.PMID:38462751 | DOI:10.1080/14740338.2024.2322116

Source: Expert Opinion on Drug Safety - March 11, 2024 Category: Drugs & Pharmacology Authors: Gareth Hughes William J Young Henry Bern Angela Crook Pier D Lambiase Ruth L Goodall Andrew J Nunn Sarah K Meredith Source Type: research